ProfileGDS4095 / 212026_s_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 67% 66% 66% 67% 67% 67% 67% 68% 67% 67% 67% 66% 66% 67% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep16.1211667
GSM709769LY2 SRC1-siRNA tamoxifen treated rep35.9760266
GSM709765LY2 SRC1-siRNA untreated rep35.9089366
GSM709771LY2 SRC1-siRNA untreated rep16.1655967
GSM709772LY2 SRC1-siRNA untreated rep26.1736767
GSM709775LY2 SRC1-siRNA untreated rep46.044367
GSM709764LY2 control-siRNA tamoxifen treated rep26.1843467
GSM709766LY2 control-siRNA tamoxifen treated rep36.2644968
GSM709768LY2 control-siRNA tamoxifen treated rep16.2419867
GSM709777LY2 control-siRNA tamoxifen treated rep46.1116367
GSM709770LY2 control-siRNA untreated rep36.187667
GSM709773LY2 control-siRNA untreated rep15.9208666
GSM709774LY2 control-siRNA untreated rep25.9149566
GSM709776LY2 control-siRNA untreated rep46.1510567